ILANIT 2023

Cholesterol modulates TGF-β receptors heterocomplex formation and their signaling in hepatocytes

Roohi Chaudhary 1 Laureen Goodman 2 Yoav I. Henis 2 Marcelo Ehrlich 1 Ralf Weiskirchen 3 Steven Dooley 4
1Shmunis School of Biomedicine and Cancer Research, Tel Aviv University, Israel
2Department of Neurobiology, Tel Aviv University, Israel
3Institute of Molecular Pathobiochemistry, Experimental Gene Therapy and Clinical Chemistry, RWTH University Hospital, Germany
4Department of Medicine II, Section Molecular Hepatology, Medical Faculty Mannheim, Heidelberg University, Germany

Cholesterol, is a membrane organizer essential for lipid raft formation and involved in multiple hepatic disorders. Cholesterol metabolism is involved in etiology of hypercholesteremia, atherosclerosis and more. Transforming growth factor-β (TGF-β) plays critical roles in different physiological processes and diseases (e.g., cancer and NAFLD/NASH). TGF-β signals through a complex of two Ser/Thr kinase recep­tors, type I and II (TβRI/II), stimulating the canonical Smad and several non-Smad signaling pathways. Despite numerous reports on TGF-β/cholesterol interdependence, the under­lying mechanisms remained elusive. To elucidate them, the effects of cholesterol depletion (CD) or enrichment (CE) on TβRI/TβRII complex formation/dynamics (+/- TGF-β1) were investigated. AML12 hepatocytes were transfected with differently-tagged TβRI/II and the effect of immobilizing TβRII by IgG crosslinking on the lateral diffusion of TβRI was measured employing FRAP. The effects on TGF-β1 signal­ing were measured using western-blotting analysis. To validate the efficacy of CD/CE, their effects on cholesterol metabolism genes were examined using qRT-PCR.

Patch/FRAP studies demonstrate TβRI/II complex formation prior to ligand bind­ing (Pre-Formed Comp­lexes; PFCs). TGF-β1 enhances TβRI/II complexes. PFCs were disrupted by CD, while TGF-β1 fully restored the complexes. CE augmented TβRI/II PFCs with minimal effect of TGF-β1 due to the already robust interactions. Of note, TGF-β1 Smad2/3 activation was unaffected by either CD/CE, indicating that this pathway doesn`t depend on rafts/caveolae (disrupted by CD). TGF-β1-signaling to PI3K/Akt was abrogated by CD indicating that it requires rafts and/or PFCs. However, this is insufficient for PI3K/Akt signaling, since it`s also lost following CE suggesting the potential involvement of other raft-resident proteins.